Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China flag China · Delayed Price · Currency is CNY
7.12
-0.12 (-1.66%)
At close: Feb 13, 2026

SHA:600866 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
15,99816,71016,89117,0743,9701,106
Other Revenue
624.13624.13482.72412.8100.9510.21
16,62217,33417,37417,4864,0711,116
Revenue Growth (YoY)
-4.66%-0.23%-0.64%329.51%264.72%6.35%
Cost of Revenue
13,39814,39314,97614,4883,276750.43
Gross Profit
3,2242,9422,3972,998794.87365.84
Selling, General & Admin
1,1091,076947.17935.84365.04139.39
Research & Development
174.29169.78179.31177.9898.8357.64
Other Operating Expenses
103.44104.9780.35118.98.2113.14
Operating Expenses
1,3811,3461,2131,236469.21210.5
Operating Income
1,8431,5961,1851,762325.66155.35
Interest Expense
-76.48-109.68-173.46-243.29-83.35-13.88
Interest & Investment Income
45.4914.8521.4315.57.267.75
Currency Exchange Gain (Loss)
37.437.4-8.33-76.916.6-2.36
Other Non Operating Income (Expenses)
-29.23-19.65-14.12-40.354.97-0.23
EBT Excluding Unusual Items
1,8201,5191,0101,417261.14146.63
Impairment of Goodwill
-91.91-91.91-93.7-12.34--
Gain (Loss) on Sale of Investments
-130.31-237.67-66.943.68.79-
Gain (Loss) on Sale of Assets
23.0728.690.34.350.831.12
Asset Writedown
-30.22-6.9-14.15-17.14-4.31-6.87
Other Unusual Items
21.4321.9227.8827.7211.8115.77
Pretax Income
1,6121,233863.621,424278.26156.64
Income Tax Expense
329.82283.27177.92240.5629.187.93
Earnings From Continuing Operations
1,282949.81685.71,183249.07148.71
Minority Interest in Earnings
-1.17-6.66-7.74-574.66-96.94-
Net Income
1,281943.15677.95608.33152.14148.71
Net Income to Common
1,281943.15677.95608.33152.14148.71
Net Income Growth
47.97%39.12%11.45%299.85%2.31%-0.56%
Shares Outstanding (Basic)
1,6611,6611,6621,188807739
Shares Outstanding (Diluted)
1,6611,6611,6621,188807739
Shares Change (YoY)
-0.03%-0.02%39.91%47.23%9.14%0.03%
EPS (Basic)
0.770.570.410.510.190.20
EPS (Diluted)
0.770.570.410.510.190.20
EPS Growth
48.01%39.14%-20.34%171.58%-6.26%-0.59%
Free Cash Flow
478.631,7591,6501,210-181.59-39.91
Free Cash Flow Per Share
0.291.060.991.02-0.23-0.05
Dividend Per Share
0.3800.3800.380---
Gross Margin
19.39%16.97%13.80%17.15%19.52%32.77%
Operating Margin
11.09%9.21%6.82%10.08%8.00%13.92%
Profit Margin
7.71%5.44%3.90%3.48%3.74%13.32%
Free Cash Flow Margin
2.88%10.15%9.50%6.92%-4.46%-3.57%
EBITDA
2,6622,4292,0352,742429.11243.28
EBITDA Margin
16.02%14.01%11.71%15.68%10.54%21.79%
D&A For EBITDA
819.59832.89850.63979.49103.4587.93
EBIT
1,8431,5961,1851,762325.66155.35
EBIT Margin
11.09%9.21%6.82%10.08%8.00%13.92%
Effective Tax Rate
20.46%22.97%20.60%16.90%10.49%5.06%
Revenue as Reported
16,62217,33417,37417,4864,0711,116
Advertising Expenses
-51.0562.4217.74.961.87
Source: S&P Global Market Intelligence. Standard template. Financial Sources.